Drug Trial News

RSS

New leukemia drug gives renewed hope to those battling drug resistance to the disease

New research offers hope for victims of chronic myeloid leukemia (CML) battling drug resistance to the disease.

18 Jun 2006

Protein represents new target in the treatment of diabetes

According to a new study elevated levels of a molecule called RBP4 (retinol binding protein 4) forecast the early stages of the development of insulin resistance, a major cause of type 2 diabetes as well as cardiovascular disease and metabolic syndrome.

18 Jun 2006

Low-dose exposure to arsenic in drinking water increases risk for skin lesions

Mailman School of Public Health study provides evidence that a population exposed to well water with arsenic concentrations of as little as 50 ug/l is at risk for skin lesions.

14 Jun 2006

Dasatinib offers new options for leukemia patients

Dasatinib, an experimental drug under development by Bristol-Myers Squibb, reverses the signs and symptoms of patients whose chronic myeloid leukemia has failed to respond to Gleevec, which is considered the standard of treatment for the disorder.

14 Jun 2006

Elevation of fat-derived molecule foretells early insulin resistance

A study in the June 15 issue of The New England Journal of Medicine (NEJM) reveals that elevated levels of a molecule called RBP4 (retinol binding protein 4) can foretell early stages in the development of insulin resistance.

14 Jun 2006

Circulating bone-marrow derived cells do not contribute to egg formation

Ovulated egg cells, or oocytes, in adult female mice are not formed from germ cells in the blood or bone marrow.

14 Jun 2006

Major intestinal surgery may boost the chances of subsequent vitamin A deficiency

Major intestinal surgery, including stomach reduction for obesity, may boost the chances of subsequent vitamin A deficiency, suggests a small study published in the British Journal of Ophthalmology.

14 Jun 2006

Restricting carbohydrates may prevent Alzheimer's disease

A recent study directed by Mount Sinai School of Medicine suggests that experimental dietary regimens might calm or even reverse symptoms of Alzheimer's Disease (AD).

14 Jun 2006

Is there an increased risk of other malignancies in patients with renal cell carcinoma?

There have been conflicting reports in the literature regarding the association of other malignancies with renal cell carcinoma (RCC).

14 Jun 2006

Comparative study of ileocecal vs. ileal neobladders in radical cystectomy patients

The use of orthotopic urinary diversion has gained increasing popularity in the past 20 years.

14 Jun 2006

Endoscopic treatment with polydimethylsiloxane in children with dilating vesico-ureteric reflux

This group from Italy assessed their endoscopic treatment of dilating vesico-ureteric reflux (VUR) in children with polydimethylsiloxane (MacroplastiqueTM, MPQ; Uroplasty BV, Geleen, The Netherlands).

14 Jun 2006

Review identifies factors that influence patient treatment choice for localized prostate cancer

Variables that influence a patients' choice of treatment for localized prostate cancer (CaP) are identified in a literature review that is authored by Dr. Zeliadt and colleagues and appears in the on-line version of Cancer, 2006.

14 Jun 2006

Smokers with wrinkled faces five times at risk of serious lung disease

New research by British scientists has found that heavy wrinkles on the faces of smokers may be an early warning sign of a serious lung disease.

14 Jun 2006

Anorexia not alleviated by anti-depressants

Patients battling to deal with the eating disorder anorexia nervosa, do not benefit or prevent relapses of the life-threatening eating disorder by taking the anti-depressant Prozac.

14 Jun 2006

New diabetic drugs could change the future for sufferers

According to the American Diabetes Association, diabetes affects as many as 21 million Americans increasing their risk of heart attacks, kidney disease and blindness.

13 Jun 2006

Prozac saves thousands of lives

A new study should help alleviate any concern over a link between the use of certain antidepressants and suicide.

13 Jun 2006

New test identifies patients who benefit from targeted cancer drugs

New lab test accurately identified patients who would benefit from treatment with the molecularly-targeted anti-cancer therapies gefitinib (Iressa, AstraZeneca) and erlotinib (Tarceva, Genentech).

13 Jun 2006

Parkinson's patients stomach new drug better than conventional meds

Several studies conducted at Baylor College of Medicine (BCM) in Houston show that a new kind of orally disintegrating tablets provides improved symptom relief for patients with Parkinson's disease.

13 Jun 2006

Duloxetine proven effective for use in men with stress urinary incontinence after radical prostatectomy

Up to 33% of patients undergoing radical prostatectomy suffer from varying degrees of incontinence.

13 Jun 2006

The n-of-1 trial: An opportunity for complementary and alternative medicine evaluation

It is an extremely interesting rationale for the use of n-of-1 randomized trials, particularly for complementary and alternative medicine evaluation in the treatment of chronic, difficult to treat disorders.

13 Jun 2006

Drug Trial News

New leukemia drug gives renewed hope to those battling drug resistance to the disease

Protein represents new target in the treatment of diabetes

Low-dose exposure to arsenic in drinking water increases risk for skin lesions

Dasatinib offers new options for leukemia patients

Elevation of fat-derived molecule foretells early insulin resistance

Circulating bone-marrow derived cells do not contribute to egg formation

Major intestinal surgery may boost the chances of subsequent vitamin A deficiency

Restricting carbohydrates may prevent Alzheimer's disease

Is there an increased risk of other malignancies in patients with renal cell carcinoma?

Comparative study of ileocecal vs. ileal neobladders in radical cystectomy patients

Endoscopic treatment with polydimethylsiloxane in children with dilating vesico-ureteric reflux

Review identifies factors that influence patient treatment choice for localized prostate cancer

Smokers with wrinkled faces five times at risk of serious lung disease

Anorexia not alleviated by anti-depressants

New diabetic drugs could change the future for sufferers

Prozac saves thousands of lives

New test identifies patients who benefit from targeted cancer drugs

Parkinson's patients stomach new drug better than conventional meds

Duloxetine proven effective for use in men with stress urinary incontinence after radical prostatectomy

The n-of-1 trial: An opportunity for complementary and alternative medicine evaluation

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Latest News